中基长寿科学(00767.HK)公布2024年业绩,收益增加约155.4%至约1.66亿港元,毛利增加约2.0%至约5740万港元,公司拥有人应占亏损3472.6万港元,同比盈转亏。
本文源自:金融界AI电报
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.